Infection with Streptococcus pneumoniae moderately resistant to penicillin does not alter clinical outcome

Infectious Diseases in Clinical Practice

Volumn 5, Issue 7, 1996, Pages 435-439

  Gress, Todd W ^a   Tingling, Kevin W ^a   Stanek, Ronald J ^a   Mufson, Maurice A ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; PENICILLIN G;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; HUMAN; MENINGITIS; PNEUMONIA; SEPSIS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 0029957434     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199609000-00010     Document Type: Article

References (20)

1. Butler JC, Breiman RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1993;270:1826-31.
2. Mufson MA. Pneumococcal infection. Curr Opinion Infect Dis 1994;7:178-83.
3. Bolan G, Broome CV, Facklam RR, et al. Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med 1988;104:1-6.
4. Jacobs MR. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin Infect Dis 1992;15:112-8.
5. Breiman RF, Butler JC, Tenover FC, et al. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994;271:1831-5.
6. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992;15:77-83.
7. Spika JS, Facklam RR, Plikaytis BD, et al. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J Infect Dis 1991;163:1273-8.
8. Liñares J, Pullares R, Alonso T, et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellridge Hospital, Barcelona, Spain. Clin Infect Dis 1992;15:99-105.
9. Stanek RJ, Mufson MA. Emergence of penicillin-resistant invasive pneumococci in a single American community. Am J Med Sci 1995;310:150-5.
10. Pallares R, Liñares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333:474-80.
11. Mufson MA, Oley G, Hughey D. Pneumococcal diseases in a medium-sized community in the United States. JAMA 1982;248:1486-9.
12. Örtqvist Å, Kalin M, Mufson MA. Deaths in bacteremic pneumococcal pneumonia: a comparison of two populations - Huntington, WV, USA and Stockholm, Sweden. Chest 1993:103:710-6.
13. Waltman WD, Gray BM, Svanborg C, et al. Epidemiologic studies of group 9 pneumococci in terms of protein type and 9N vs. 9V capsular type. J Infect Dis 1991;163:812-8.
14. Clark RB, Gigar O, Mortensen JE. Comparison of susceptibility test methods to detect penicillin-resistant Streptococcus pneumoniae. Diagn Microbiol Infect Dis 1993;17: 213-7.
15. Jacobs MR, Bajaksouzian S, Appelbaum PC, et al. Evaluation of the E test for susceptibility testing of pneumococci. Diagn Microbiol Infect Dis 1992;15:473-8.
16. Krisher KK, Linscott A. Comparison of three commercial MIC systems, E test, fastidious antimicrobial susceptibility panel, and FOX fastidious panel, for confirmation of penicillin and cephalosporin resistance in Streptococcus pneumoniae. J Clin Microbiol 1994;32:2242-5.
17. Macias EA, Mason EOJr, Ocera HY, et al. Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae. J Clin Microbiol 1994;32:430-2.
18. Jorgensen JH, Ferraro MJ, McElmeel ML, et al. Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test. J Clin Microbiol 1994;32:159-63.
19. Marton A, Gulyas M, Munoz R, et al. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J Infect Dis 1991; 163:542-8.
20. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333:481-6.